NDC 54868-5653

Advicor

Niacin And Lovastatin

Advicor is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Physicians Total Care, Inc.. The primary component is Niacin; Lovastatin.

• Product ID: 54868-5653_0b937ee5-f2c3-48a9-87d2-f0689ff39043
• NDC: 54868-5653
• Product Type: Human Prescription Drug
• Proprietary Name: Advicor
• Generic Name: Niacin And Lovastatin
• Dosage Form: Tablet, Extended Release
• Route of Administration: ORAL
• Marketing Start Date: 2006-08-08
• Marketing Category: NDA / NDA
• Application Number: NDA021249
• Labeler Name: Physicians Total Care, Inc.
• Substance Name: NIACIN; LOVASTATIN
• Active Ingredient Strength: 1000 mg/1; mg/1
• Pharm Classes: Nicotinic Acid [EPC],Nicotinic Acids [CS],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 54868-5653-0

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (54868-5653-0)

• Marketing Start Date: 2006-08-08
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 54868-5653-1 [54868565301]

Advicor TABLET, EXTENDED RELEASE

• Marketing Category: NDA
• Application Number: NDA021249
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2010-09-07
• Inactivation Date: 2019-09-24

NDC 54868-5653-0 [54868565300]

Advicor TABLET, EXTENDED RELEASE

• Marketing Category: NDA
• Application Number: NDA021249
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2006-08-08
• Inactivation Date: 2019-09-24

Drug Details

Active Ingredients

Ingredient	Strength
NIACIN	1000 mg/1

OpenFDA Data

• SPL SET ID: dbdee4c0-86fa-4857-b536-79bf9ebb911a
• Manufacturer:
  • Physicians Total Care, Inc.
• UNII:
  • 2679MF687A
  • 9LHU78OQFD
• RxNorm Concept Unique ID - RxCUI:
  • 791846
  • 582043
  • 582042
  • 582041
  • 791842
  • 644112
  • 791834
  • 791838

Pharmacological Class

• Nicotinic Acid [EPC]
• Nicotinic Acids [CS]
• HMG-CoA Reductase Inhibitor [EPC]
• Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]